Challenging Invasive Fungal Infections: Risk Assessment and Diagnosis

Target Audience
Primary audience: This activity is directed to infectious disease physicians, critical care physicians, hospitalists, surgeons, pathologists/clinical microbiologists, hematologists/oncologists, pharmacists, pediatric infectious disease specialists, transplant specialists, and other healthcare providers responsible for the management of invasive fungal infections.

Secondary audience: Primary care providers, GI, dermatology, and rheumatology specialists who work in the endemic areas or who see patients receiving biologics who are at risk for endemic mycoses.

Program Overview
Featuring cases from the virtual live event MSGERC Town Hall: Challenging Invasive Fungal Infections, this enduring activity will address identifying at-risk patients and securing the invasive fungal infections (IFIs) diagnosis. It will highlight the problem with low awareness of endemic mycoses as potential causes of CAP, and the importance of appropriate use of antifungal susceptibility testing.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the epidemiology of invasive fungal infections
Define risk factors for invasive mold infections and coccidioidomycosis
Diagnose challenging invasive fungal infections
Utilize antifungal susceptibility testing appropriately in the management of invasive fungal infections